Matthew Robson
| Matthew Robson FREng | |
|---|---|
| Born | Matthew David Robson |
| 🎓 Alma mater | University of Cambridge |
| 💼 Occupation | |
| Known for | Quantitative MRI, medical imaging technologies |
Matthew David Robson FREng is a British engineer, academic, and technology executive specializing in magnetic resonance imaging (MRI), medical imaging, and quantitative image analysis. He is currently the Chief Technology Officer and a co-founder of Perspectum, and was formerly a Professor of MR Physics at the University of Oxford. He was elected a Fellow of the Royal Academy of Engineering in 2024.
Career
Robson began his career as a postdoctoral researcher at Yale University before moving into industry roles in medical imaging.[1]
From 2001, Robson worked at the Oxford Centre for Clinical Magnetic Resonance Research at the University of Oxford.[2] He served as a research physicist and later as a university research lecturer. From 2014 to 2017, he was professor and director of MR physics at the Oxford Centre for Clinical Magnetic Resonance Research, where his responsibilities included MRI methods development and work on clinical research MRI systems at 1.5T, 3T, and 7T.[3]
In 2012, Robson co-founded Perspectum with Stefan Neubauer, Rajarshi Banerjee, and Michael Brady.[4] He has served as chief technology officer since 2017.[5]
Robson was elected a Fellow of the Royal Academy of Engineering in 2024.[1]
Research
Robson's research has focused on magnetic resonance imaging (MRI), with emphasis on quantitative imaging, cardiac magnetic resonance imaging, medical image analysis, and MRI-derived biomarkers. His early research included work on functional magnetic resonance imaging and ultrafast imaging methods at the Yale School of Medicine.[1]
At the University of Oxford, Robson worked on cardiovascular magnetic resonance imaging, including cardiac imaging at 3 Tesla, myocardial T1 mapping, and magnetic resonance spectroscopy.[1] He was involved in research on Shortened Modified Look-Locker Inversion Recovery (ShMOLLI), a method used for myocardial T1 mapping during a short breath-hold.[6] His work has also examined myocardial T1 measurement and the effects of magnetization transfer on cardiac MRI sequences.[7]
Robson has contributed to research on cardiac phosphorus-31 magnetic resonance spectroscopy, including studies comparing cardiac spectroscopy at 1.5T and 3T and later work on human cardiac spectroscopy at 7T.[8][9] He has also contributed to book chapters on the principles and methods of cardiovascular magnetic resonance.[10]
Robson has worked on ultrashort echo time (UTE) MRI, which is used to image tissues with very short T2 relaxation times, such as bone and connective tissue. He co-authored studies on phosphorus imaging of cortical and trabecular bone, cortical bone imaging using UTE pulse sequences, and clinical applications of UTE imaging.[11][12][13] He also co-authored a chapter on phase-contrast UTE imaging of very fast flows.[14]
His research has included quantitative MRI methods for vascular imaging and atherosclerosis assessment. He was a co-author of a study on in-vivo quantitative T2 mapping of carotid arteries in patients with atherosclerosis, which examined the use of T2 maps for plaque classification and measurement of plaque components.[15]
His later work has included quantitative MRI methods for liver disease assessment. He was a co-author of a 2014 study in the Journal of Hepatology on multiparametric magnetic resonance imaging for the non-invasive assessment of liver disease.[16] A later study examined the use of multiparametric MRI in patients with chronic liver disease and its association with clinical outcomes.[17]
References
- ↑ 1.0 1.1 1.2 1.3 "Professor Matthew Robson FREng". Royal Academy of Engineering.
- ↑ "Neubauer Group: Oxford Centre for Clinical Magnetic Resonance Research". Radcliffe Department of Medicine.
- ↑ "Contacts for Imaging | NIHR Biomedical Research Centre". Oxford.
- ↑ "Finding the silent killer". Oxford Mail. 17 April 2014.
- ↑ "Perspectum". The Sunday Times. 16 January 2026.
- ↑ Piechnik, Stefan K; Ferreira, Vanessa M; Dall'Armellina, Erica; Cochlin, Lowri E; Greiser, Andreas; Neubauer, Stefan; Robson, Matthew D (October 2010). "Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold". Journal of Cardiovascular Magnetic Resonance. 12 (1): 69. doi:10.1186/1532-429X-12-69.
- ↑ Robson, Matthew D.; Piechnik, Stefan K.; Tunnicliffe, Elizabeth M.; Neubauer, Stefan (2013). "T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences". Magnetic Resonance in Medicine. 70 (3): 664–670. doi:10.1002/mrm.24867. PMID 23857710.
- ↑ Tyler, Damian J.; Hudsmith, Lucy E.; Clarke, Kieran; Neubauer, Stefan; Robson, Matthew D. (2008). "A comparison of cardiac 31P MRS at 1.5 and 3 T". NMR in Biomedicine. 21 (8): 793–798. doi:10.1002/nbm.1255.
- ↑ Rodgers, Christopher T.; Clarke, William T.; Snyder, Curtis; Vaughan, J. Thomas; Neubauer, Stefan; Robson, Matthew D. (2014). "Human cardiac 31P magnetic resonance spectroscopy at 7 tesla". Magnetic Resonance in Medicine. 72 (2): 304–315. doi:10.1002/mrm.24922. PMID 24006267.
- ↑ Selvanayagam, Joseph; Robson, Matthew D.; Francis, Jane; Neubauer, Stefan. "Basic Principles, Methods, and Techniques". Cardiac CT, PET and MR. Wiley-Blackwell. ISBN 978-1-4051-8553-0. Search this book on
- ↑ Robson, Matthew D.; Gatehouse, Peter D.; Bydder, Graeme M.; Neubauer, Stefan (2004). "Human imaging of phosphorus in cortical and trabecular bone in vivo". Magnetic Resonance in Medicine. 51 (5): 888–892. doi:10.1002/mrm.20055. PMID 15122669.
- ↑ Reichert, Ines L. H.; Robson, Matthew D.; Gatehouse, Peter D.; He, Taigang; Chappell, Karyn E.; Holmes, Joanne; Girgis, Samia; Bydder, Graeme M. (2005). "Magnetic resonance imaging of cortical bone with ultrashort TE pulse sequences". Magnetic Resonance Imaging. 23 (5): 611–618. doi:10.1016/j.mri.2005.02.017. PMID 16051035.
- ↑ Robson, Matthew D.; Bydder, Graeme M. (2006). "Clinical ultrashort echo time imaging of bone and other connective tissues". NMR in Biomedicine. 19 (7): 765–780. doi:10.1002/nbm.1100. PMID 17075960.
- ↑ O'Brien, Kieran R.; Robson, Matthew D. (2012). "Imaging of Very Fast Flows with PC-UTE". Encyclopedia of Magnetic Resonance. John Wiley & Sons. pp. 521–528. doi:10.1002/9780470034590.emrstm1248. Search this book on
- ↑ Biasiolli, Luca; Lindsay, Alistair C.; Chai, Joshua T.; Choudhury, Robin P.; Robson, Matthew D. (2013). "In-vivo quantitative T2 mapping of carotid arteries in atherosclerotic patients: segmentation and T2 measurement of plaque components". Journal of Cardiovascular Magnetic Resonance. 15: 69. doi:10.1186/1532-429X-15-69.
- ↑ Banerjee, Rajarshi; Pavlides, Michael; Tunnicliffe, Elizabeth M.; Piechnik, Stefan K.; Sarania, Nikita; Philips, Rachel; Collier, Jane D.; Booth, Jonathan C.; Schneider, Jürgen E.; Wang, Lai Mun; Delaney, David W.; Fleming, Kenneth; Robson, Matthew D.; Barnes, Eleanor; Neubauer, Stefan (2014). "Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease". Journal of Hepatology. 60 (1): 69–77. doi:10.1016/j.jhep.2013.09.002. PMID 24036007.
- ↑ Pavlides, Michael; Banerjee, Rajarshi; Tunnicliffe, Elizabeth M.; Kelly, Christopher; Collier, Jane; Booth, Jonathan; Houlston, Robert; Neubauer, Stefan; Barnes, Eleanor; Robson, Matthew D. (2016). "Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease". Journal of Hepatology. 64 (2): 308–315. doi:10.1016/j.jhep.2015.10.009. PMID 26471505.
This article "Matthew D. Robson" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Matthew D. Robson. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
